TEM news

Tempus AI, Inc. · end-of-day data as of Nov 13, 2026

Tempus AI

TEM · $12.7B

$71.60-5.7%

Nov 13, 2026 · close

▲ 5

PT$78.63 +9.8%
ConsensusBuy · 21
Trendbullish
MA20×50Golden 3d ago
Sector▲ +15.9%

Neutral

Earnings in102d
RSI47
Support-2.1%
Resistance+1.9%
Off 52w high-19.6%
Volume0.8x
Bollingerlower half
News0.00
52w range$41–$89
ATR+9.5%
Off ATH-31.4%
MAs2 of 4

▼ 3

FCF yield-1.2%
Insiders-$89.37M
MACD-0.01

Updates with the 15-min delayed price. Not a forecast or investment advice.

Last session

News0.00

Headlines

Arizona Eagle Mining Corp. Announces Completion of High Resolution TEM Geophysical Survey at the Eagle Project and Provides Update on McCabe Mine Reopening Studies
Newsfile Corp · Nov 12, 2026
Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual Meeting
Business Wire · Nov 11, 2026
Blood Cancer United Launches REALworld: AML to Accelerate New Treatments for Children with Blood Cancer
PRNewsWire · Nov 10, 2026
SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer
PRNewsWire · Nov 9, 2026
Tempus AI: Q3 Strengthens The Platform Thesis, But Cash Returns Still Need To Catch Up
Seeking Alpha · Nov 7, 2026
Tempus AI: An Inflection Point Has Arrived (Earnings Analysis)
Seeking Alpha · Nov 4, 2026
Tempus AI Surges on Earnings Beat, But Can the Rally Last?
MarketBeat · Nov 3, 2026
TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside
Zacks Investment Research · Nov 3, 2026
Baron SMID Cap ETF Q3 2026 Contributors And Detractors
Seeking Alpha · Nov 3, 2026
Tempus AI Analysts Boost Their Forecasts Following Strong Q3 Results
Benzinga · Nov 3, 2026
3 Stocks to Watch Following Guidance Upgrades
Zacks Investment Research · Nov 2, 2026
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
24/7 Wall Street · Nov 2, 2026
Tempus AI, Inc. (TEM) Q3 2026 Earnings Call Transcript
Seeking Alpha · Nov 2, 2026
Tempus AI Says It Is Uniquely Positioned
Benzinga · Nov 2, 2026
Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say
Zacks Investment Research · Nov 2, 2026
Tempus AI (TEM) Beats Q3 Earnings and Revenue Estimates
Zacks Investment Research · Nov 2, 2026
What Tempus AI (TEM) Said on Its Q3 Earnings Call
MarketBeat · Nov 2, 2026
Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction
The Motley Fool · Nov 2, 2026
Tempus AI's Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer
Barrons · Nov 2, 2026
Tempus Reports Third Quarter 2026 Results
Business Wire · Nov 2, 2026
Head-To-Head Contrast: Tempus AI (NASDAQ:TEM) versus P3 Health Partners (NASDAQ:PIII)
Defense World · Nov 2, 2026
Tempus AI (NASDAQ:TEM) Stock: Insider Eric Lefkofsky Sells 250,000 Shares
Defense World · Oct 31, 2026
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?
Zacks Investment Research · Oct 30, 2026
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
24/7 Wall Street · Oct 27, 2026
Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research · Oct 26, 2026
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Business Wire · Oct 26, 2026
Tempus AI: Less Risky Than When I Said Buy
Seeking Alpha · Oct 23, 2026
Tempus Expands Strategic Collaboration with Bristol Myers Squibb
Business Wire · Oct 23, 2026
Pathos AI Announces Strategic Collaborations with Bristol Myers Squibb and Tempus AI to Advance AI-Driven Drug Development Beginning with Alzheimer's Disease and Other Neurological Conditions
Business Wire · Oct 23, 2026
Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch
Seeking Alpha · Oct 23, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.